History


2015

Acquisition of segments of BASF's pharmaceutical supply business in Minden (Germany), Evionnaz (Switzerland) and St. Vulbas (France)

Siegfried Evionnaz SA, Switzerland
Siegfried St. Vulbas SAS, France
Siegfried PharmaChemikalien, Germany

2014

Acquisition of Hameln Pharma in Hameln (Germany)

Siegfried Hameln, Germany

2013

Construction of new production sites
Nantong (China) and Zofingen (Switzerland)


2012

Acquisition of Alliance Medical Products (AMP)
in Irvine (CA, USA)


2010

Definition of new strategy "Transform". Implementation of a new function-based organization. New investors and capital increase. Sale of the Munich (Germany) subsidiary (Pulmojet project) to Sanofi-Aventis.


2008

Sale of the pharmaceutical production site at
Zofingen to Arena Pharmaceuticals


2007

Launch of a pharmaceutical production facility in Malta. Ramp up of an inhalation technology team in Munich (Germany). Sale of the Sidroga Division and the biotechnology division. Cooperation agreement with Arena Pharmaceuticals.


2006

Cooperation agreement with Celgene


2005

Acquisition of Penick Corporation in New Jersey (USA)


2004

Establishment of a representative office in Shanghai (China)


2002

Integration of Gane's into Siegfried Group
as Siegfried (USA) Inc.


2001

Establishment of two core divisions: Siegfried and Sidroga


1973

Listing on the Swiss Stock Exchange (SWX) in Basel


1928

Founding of Gane's Chemical Works, Inc. (NJ, USA)

Siegfried Zofingen 1920

1904

Conversion into a joint stock corporation


1873

Founding of a company with 12 employees by pharmacist Samuel Benoni Siegfried to supply pharmacies

to the top to top

Can't find the information
you are looking for?
Contact us

Siegfried AG
Untere Bruehlstrasse 4
CH-4800 Zofingen

Phone: +41 62 746 1111
Fax: +41 62 746 1202
info@siegfried.ch